← Open Payments lookup

MARIBETH HATALSKI: Open Payments

NPI 1023426954 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,652 in 142 payments from 20 companies in 2025. Trend: 2023 $2,116 · 2024 $3,436 · 2025 $3,652

Food & beverage: $3,568Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.25$833
ABBVIE INC.21$532
Ardelyx, Inc.10$380
Takeda Pharmaceuticals U.S.A., Inc.16$368
Madrigal Pharmaceuticals12$274
PFIZER INC.10$260
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$259
QOL Medical, LLC12$186
GENZYME CORPORATION5$103
Ipsen Biopharmaceuticals, Inc4$91

Products named: TREMFYA, IBSRELA, RINVOQ, ENTYVIO, REZDIFFRA, XIFAXAN, Sucraid, VELSIPITY.

Industry payments across MD — which companies pay providers there.